Peter W Brown, MD
Family Practice · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brown’s office at (650) 941-4545 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$27,105
Medicare paid this office $27,105 for 90 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 74 | $13,328 | $98 |
| Long return visit (40+ min) | 30 | $4,453 | $131 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,677 | $141 |
| Short return visit (20+ min) | 24 | $2,674 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $160 | $12 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
90 Original Medicare patients in 2024. Average age 77 · Under 65 0% · 85 and older 16% · Women 32% · Health risk score 0.70. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 48% · Coronary heart disease 21% · Cancer 17% · Atrial fibrillation 16%.
The office billed $45,451, Medicare allowed $38,963 and paid $27,105; for 324 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 90 | 324 | 77 | 0.70 | $45,451 | $27,105 |
| 2023 | 91 | 349 | 78 | 0.71 | $44,847 | $27,734 |
| 2022 | 76 | 249 | 77 | 0.79 | $33,450 | $20,690 |
| 2021 | 81 | 263 | 76 | 0.76 | $36,869 | $23,318 |
| 2020 | 89 | 305 | 77 | 0.87 | $35,798 | $22,705 |
| 2019 | 113 | 367 | 78 | 0.98 | $45,102 | $28,148 |
| 2018 | 116 | 385 | 77 | 0.87 | $47,193 | $29,445 |
| 2017 | 108 | 351 | 77 | 0.88 | $42,268 | $25,295 |
| 2016 | 121 | 414 | 77 | 0.78 | $48,803 | $29,745 |
| 2015 | 131 | 435 | 76 | 0.84 | $49,331 | $30,093 |
| 2014 | 137 | 491 | 76 | 0.86 | $55,764 | $35,086 |
| 2013 | 126 | 468 | 77 | 0.80 | $51,832 | $32,491 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 71 | $13,684 | $95 |
| Long return visit (40+ min) | 24 | $4,636 | $145 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,218 | $146 |
| Short return visit (20+ min) | 24 | $3,073 | $65 |
| Insertion of needle into vein for collection of blood sample | 16 | $143 | $8 |
2022: 5 services
| Return visit (30+ min) | 58 | $10,305 | $95 |
| Long return visit (40+ min) | 22 | $4,044 | $144 |
| Short return visit (20+ min) | 28 | $2,917 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $119 | $10 |
| Insertion of needle into vein for collection of blood sample | 13 | $39 | $3 |
2021: 4 services
| Return visit (30+ min) | 71 | $14,273 | $100 |
| Long return visit (40+ min) | 15 | $2,396 | $150 |
| Short return visit (20+ min) | 25 | $2,185 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $168 | $12 |
2020: 4 services
| Return visit (30+ min) | 72 | $13,405 | $90 |
| Short return visit (20+ min) | 31 | $2,922 | $60 |
| Long return visit (40+ min) | 23 | $2,668 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $225 | $13 |
2019: 4 services
| Return visit (30+ min) | 79 | $15,070 | $87 |
| Long return visit (40+ min) | 36 | $4,360 | $112 |
| Short return visit (20+ min) | 37 | $3,108 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $267 | $14 |
2018: 6 services
| Return visit (30+ min) | 91 | $13,961 | $78 |
| Long return visit (40+ min) | 37 | $5,225 | $114 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $3,802 | $127 |
| Short return visit (20+ min) | 22 | $1,692 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $208 | $14 |
| Insertion of needle into vein for collection of blood sample | 11 | $32 | $3 |
2017: 4 services
| Return visit (30+ min) | 82 | $13,275 | $77 |
| Long return visit (40+ min) | 27 | $3,341 | $104 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,000 | $125 |
| Short return visit (20+ min) | 32 | $1,540 | $41 |
2016: 5 services
| Return visit (30+ min) | 91 | $13,742 | $82 |
| Short return visit (20+ min) | 66 | $5,023 | $50 |
| Long return visit (40+ min) | 27 | $3,399 | $113 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,261 | $126 |
| Destruction of precancer skin growth, 1 growth | 11 | $603 | $55 |
2015: 5 services
| Return visit (30+ min) | 103 | $14,925 | $81 |
| Short return visit (20+ min) | 65 | $5,648 | $51 |
| Long return visit (40+ min) | 20 | $2,352 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,394 | $127 |
| Destruction of precancer skin growth, 1 growth | 11 | $515 | $43 |
2014: 8 services
| Return visit (30+ min) | 87 | $12,782 | $79 |
| Short return visit (20+ min) | 70 | $6,252 | $57 |
| Long return visit (40+ min) | 31 | $4,016 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $1,882 | $125 |
| Destruction of precancer skin growth, 1 growth | 14 | $900 | $60 |
| Administration of influenza virus vaccine | 13 | $366 | $28 |
| Destruction of precancer skin growth, 2-14 growths | 11 | $330 | $9 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 13 | $160 | $12 |
2013: 5 services
| Return visit (30+ min) | 81 | $13,441 | $85 |
| Short return visit (20+ min) | 61 | $6,017 | $55 |
| Long return visit (40+ min) | 33 | $3,722 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,492 | $124 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $300 | $14 |
Drugs they prescribed that Part D paid
$34,313
Pharmacies billed $34,313 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (52 of 707) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%.
651 generic and fewer than 11 brand-name prescriptions · $34,313 in drug cost · 47 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 52 | $4,633 | $89 |
| Breo Ellipta | 11 | $4,405 | $400 |
| Atorvastatin | 97 | $826 | $9 |
| Levothyroxine | 44 | $770 | $17 |
| Omeprazole | 12 | $414 | $35 |
See all 20 drugs
| Hydrocodone-Acetaminophen | 52 | $4,633 | $89 |
| Breo Ellipta | 11 | $4,405 | $400 |
| Atorvastatin | 97 | $826 | $9 |
| Levothyroxine | 44 | $770 | $17 |
| Omeprazole | 12 | $414 | $35 |
| Albuterol Sulfate Hfa | 15 | $351 | $23 |
| Tamsulosin | 14 | $340 | $24 |
| Rosuvastatin | 22 | $303 | $14 |
| Fluoxetine | 16 | $206 | $13 |
| Metformin | 16 | $199 | $12 |
| Lisinopril | 29 | $186 | $6 |
| Zolpidem | 31 | $184 | $6 |
| Lorazepam | 15 | $161 | $11 |
| Metoprolol | 12 | $123 | $10 |
| Losartan | 22 | $90 | $4 |
| Azithromycin | 17 | $76 | $4 |
| Trazodone | 14 | $74 | $5 |
| Warfarin | 12 | $50 | $4 |
| Allopurinol | 15 | $48 | $3 |
| Amlodipine Besylate | 11 | $27 | $2 |
Year by year
| 2024 | 707 | 85 | 7% (52) | None | $34,313 |
| 2023 | 671 | 82 | 7% (47) | None | $40,215 |
| 2022 | 689 | 89 | 7% (46) | None | $25,957 |
| 2021 | 832 | 89 | 4% (34) | 6% | $26,040 |
| 2020 | 924 | 99 | 3% (25) | 8% | $41,907 |
| 2019 | 974 | 114 | 3% (27) | 8% | $42,091 |
| 2018 | 991 | 107 | 3% (25) | 8% | $36,550 |
| 2017 | 1,011 | 99 | 3% (32) | 10% | $45,978 |
| 2016 | 941 | 91 | 4% (34) | 11% | $57,027 |
| 2015 | 998 | 96 | 5% (53) | 19% | $63,510 |
| 2014 | 852 | 86 | 4% (35) | 24% | $55,138 |
| 2013 | 889 | 75 | 6% (52) | None | $68,805 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Breo Ellipta | 11 | $4,700 | $427 |
| Hydrocodone-Acetaminophen | 42 | $2,423 | $58 |
| Atorvastatin | 95 | $1,034 | $11 |
| Levothyroxine | 33 | $544 | $16 |
| Rosuvastatin | 23 | $539 | $23 |
| Dextroamphetamine-Amphetamine | 11 | $467 | $42 |
| Atenolol | 24 | $290 | $12 |
| Losartan | 19 | $279 | $15 |
| Lisinopril | 22 | $219 | $10 |
| Allopurinol | 15 | $219 | $15 |
| Hydralazine | 11 | $181 | $16 |
| Zolpidem | 26 | $151 | $6 |
| Metformin | 13 | $146 | $11 |
| Warfarin | 12 | $139 | $12 |
| Diazepam | 14 | $135 | $10 |
| Triamterene-Hydrochlorothiazid | 12 | $129 | $11 |
| Fluoxetine | 12 | $60 | $5 |
| Lorazepam | 14 | $52 | $4 |
| Amlodipine Besylate | 12 | $50 | $4 |
| Lisinopril-Hydrochlorothiazide | 13 | $33 | $3 |
2022: 20 drugs
| Hydrocodone-Acetaminophen | 43 | $1,601 | $37 |
| Atorvastatin | 95 | $986 | $10 |
| Pentoxifylline | 12 | $927 | $77 |
| Rosuvastatin | 18 | $587 | $33 |
| Levothyroxine | 30 | $489 | $16 |
| Losartan | 22 | $448 | $20 |
| Warfarin | 14 | $395 | $28 |
| Metoprolol | 13 | $295 | $23 |
| Zolpidem | 24 | $277 | $12 |
| Allopurinol | 16 | $276 | $17 |
| Lorazepam | 18 | $252 | $14 |
| Atenolol | 31 | $222 | $7 |
| Tamsulosin | 12 | $181 | $15 |
| Metformin | 11 | $118 | $11 |
| Lisinopril | 29 | $112 | $4 |
| Hydralazine | 12 | $87 | $7 |
| Diazepam | 13 | $82 | $6 |
| Triamterene-Hydrochlorothiazid | 13 | $63 | $5 |
| Amlodipine Besylate | 12 | $52 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $20 | $2 |
2021: 22 drugs
| Ezetimibe | 14 | $1,189 | $85 |
| Hydrocodone-Acetaminophen | 32 | $1,126 | $35 |
| Atorvastatin | 105 | $1,122 | $11 |
| Levothyroxine | 39 | $894 | $23 |
| Rosuvastatin | 19 | $601 | $32 |
| Metoprolol | 17 | $425 | $25 |
| Triamterene-Hydrochlorothiazid | 31 | $383 | $12 |
| Atenolol | 32 | $317 | $10 |
| Zolpidem | 28 | $296 | $11 |
| Tamsulosin | 18 | $270 | $15 |
| Losartan | 16 | $265 | $17 |
| Allopurinol | 16 | $262 | $16 |
| Amlodipine Besylate | 28 | $200 | $7 |
| Haloperidol | 12 | $173 | $14 |
| Alendronate | 14 | $153 | $11 |
| Divalproex | 13 | $125 | $10 |
| Lisinopril | 33 | $116 | $4 |
| Lorazepam | 16 | $105 | $7 |
| Diazepam | 13 | $90 | $7 |
| Hydralazine | 13 | $90 | $7 |
| Prednisone | 16 | $72 | $4 |
| Hydrochlorothiazide | 11 | $30 | $3 |
2020: 29 drugs
| Eliquis | 14 | $7,982 | $570 |
| Ezetimibe | 18 | $2,320 | $129 |
| Atorvastatin | 133 | $1,956 | $15 |
| Levothyroxine | 45 | $991 | $22 |
| Hydrocodone-Acetaminophen | 21 | $907 | $43 |
| Rifampin | 12 | $611 | $51 |
| Rosuvastatin | 14 | $598 | $43 |
| Metoprolol | 20 | $499 | $25 |
| Dextroamphetamine-Amphetamine | 11 | $495 | $45 |
| Losartan | 23 | $469 | $20 |
| Warfarin | 11 | $388 | $35 |
| Doxycycline Monohydrate | 12 | $352 | $29 |
| Atenolol | 26 | $334 | $13 |
| Tamsulosin | 14 | $318 | $23 |
| Lorazepam | 35 | $308 | $9 |
| Triamterene-Hydrochlorothiazid | 19 | $252 | $13 |
| Zolpidem | 22 | $242 | $11 |
| Pantoprazole | 11 | $229 | $21 |
| Escitalopram | 14 | $219 | $16 |
| Lisinopril | 42 | $182 | $4 |
| Amlodipine Besylate | 26 | $181 | $7 |
| Allopurinol | 11 | $151 | $14 |
| Clopidogrel | 13 | $147 | $11 |
| Metformin | 14 | $128 | $9 |
| Metformin Hcl Er | 16 | $100 | $6 |
| Diazepam | 12 | $96 | $8 |
| Azithromycin | 11 | $55 | $5 |
| Hydrochlorothiazide | 11 | $52 | $5 |
| Prednisone | 11 | $48 | $4 |
2019: 29 drugs
| Atorvastatin | 133 | $2,246 | $17 |
| Ezetimibe | 28 | $2,036 | $73 |
| Hydrocodone-Acetaminophen | 24 | $1,012 | $42 |
| Levothyroxine | 43 | $925 | $22 |
| Metoprolol | 18 | $760 | $42 |
| Losartan | 28 | $585 | $21 |
| Warfarin | 12 | $573 | $48 |
| Rosuvastatin | 19 | $515 | $27 |
| Omeprazole | 12 | $512 | $43 |
| Atenolol | 33 | $480 | $15 |
| Lorazepam | 44 | $379 | $9 |
| Allopurinol | 12 | $356 | $30 |
| Amlodipine Besylate | 21 | $354 | $17 |
| Tamsulosin | 14 | $298 | $21 |
| Pantoprazole | 13 | $248 | $19 |
| Ramipril | 14 | $230 | $16 |
| Metformin | 21 | $229 | $11 |
| Lisinopril | 38 | $226 | $6 |
| Escitalopram | 18 | $212 | $12 |
| Clopidogrel | 13 | $185 | $14 |
| Zolpidem | 17 | $172 | $10 |
| Triamterene-Hydrochlorothiazid | 11 | $131 | $12 |
| Memantine | 12 | $128 | $11 |
| Diazepam | 13 | $109 | $8 |
| Azithromycin | 15 | $104 | $7 |
| Metformin Hcl Er | 14 | $92 | $7 |
| Hydrochlorothiazide | 11 | $68 | $6 |
| Furosemide | 13 | $65 | $5 |
| Alprazolam | 22 | $61 | $3 |
2018: 27 drugs
| Atorvastatin | 135 | $2,665 | $20 |
| Ezetimibe | 22 | $2,156 | $98 |
| Hydrocodone-Acetaminophen | 24 | $1,171 | $49 |
| Metoprolol | 20 | $1,063 | $53 |
| Levothyroxine | 52 | $1,062 | $20 |
| Warfarin | 22 | $737 | $34 |
| Tamsulosin | 20 | $598 | $30 |
| Dextroamphetamine-Amphetamine | 13 | $448 | $34 |
| Losartan | 27 | $415 | $15 |
| Omeprazole | 15 | $400 | $27 |
| Valsartan | 11 | $367 | $33 |
| Lorazepam | 31 | $319 | $10 |
| Rosuvastatin | 16 | $318 | $20 |
| Atenolol | 23 | $278 | $12 |
| Metformin | 23 | $229 | $10 |
| Ramipril | 13 | $211 | $16 |
| Amlodipine Besylate | 12 | $209 | $17 |
| Lisinopril | 34 | $200 | $6 |
| Memantine | 12 | $198 | $17 |
| Simvastatin | 18 | $197 | $11 |
| Zolpidem | 12 | $193 | $16 |
| Diazepam | 13 | $150 | $12 |
| Alprazolam | 44 | $130 | $3 |
| Azithromycin | 17 | $124 | $7 |
| Metformin Hcl Er | 13 | $124 | $10 |
| Furosemide | 29 | $122 | $4 |
| Hydrochlorothiazide | 12 | $63 | $5 |
2017: 31 drugs
| Zetia | 11 | $7,697 | $700 |
| Advair Diskus | 11 | $4,130 | $375 |
| Ezetimibe | 14 | $3,756 | $268 |
| Atorvastatin | 119 | $1,698 | $14 |
| Levothyroxine | 57 | $1,182 | $21 |
| Metoprolol | 16 | $1,049 | $66 |
| Tamsulosin | 21 | $668 | $32 |
| Allopurinol | 21 | $650 | $31 |
| Hydrocodone-Acetaminophen | 25 | $625 | $25 |
| Warfarin | 39 | $615 | $16 |
| Dextroamphetamine-Amphetamine | 13 | $519 | $40 |
| Memantine | 16 | $450 | $28 |
| Omeprazole | 14 | $400 | $29 |
| Losartan | 41 | $390 | $10 |
| Zolpidem | 11 | $343 | $31 |
| Atenolol | 37 | $331 | $9 |
| Ramipril | 15 | $284 | $19 |
| Triamterene-Hydrochlorothiazid | 22 | $240 | $11 |
| Metformin | 22 | $203 | $9 |
| Amlodipine Besylate | 21 | $203 | $10 |
| Finasteride | 11 | $186 | $17 |
| Potassium Chloride | 13 | $186 | $14 |
| Diazepam | 17 | $182 | $11 |
| Azithromycin | 24 | $166 | $7 |
| Simvastatin | 14 | $162 | $12 |
| Lisinopril | 32 | $154 | $5 |
| Lorazepam | 12 | $139 | $12 |
| Furosemide | 29 | $110 | $4 |
| Alprazolam | 31 | $93 | $3 |
| Clopidogrel | 11 | $79 | $7 |
| Escitalopram | 11 | $68 | $6 |
2016: 26 drugs
| Zetia | 26 | $19,844 | $763 |
| Advair Diskus | 16 | $5,395 | $337 |
| Atorvastatin | 100 | $1,739 | $17 |
| Hydrocodone-Acetaminophen | 29 | $1,213 | $42 |
| Dextroamphetamine-Amphetamine | 26 | $1,052 | $40 |
| Allopurinol | 31 | $908 | $29 |
| Levothyroxine | 31 | $818 | $26 |
| Tamsulosin | 28 | $797 | $28 |
| Omeprazole | 21 | $693 | $33 |
| Zolpidem | 19 | $573 | $30 |
| Losartan | 44 | $378 | $9 |
| Atenolol | 36 | $300 | $8 |
| Triamterene-Hydrochlorothiazid | 26 | $246 | $9 |
| Lisinopril | 32 | $226 | $7 |
| Finasteride | 14 | $207 | $15 |
| Escitalopram | 13 | $206 | $16 |
| Pravastatin | 12 | $196 | $16 |
| Isosorbide Mononitrate Er | 12 | $196 | $16 |
| Metformin | 20 | $179 | $9 |
| Alprazolam | 31 | $172 | $6 |
| Azithromycin | 20 | $169 | $8 |
| Clopidogrel | 16 | $153 | $10 |
| Lorazepam | 13 | $118 | $9 |
| Diazepam | 15 | $117 | $8 |
| Amlodipine Besylate | 21 | $111 | $5 |
| Furosemide | 18 | $66 | $4 |
2015: 30 drugs
| Zetia | 35 | $17,978 | $514 |
| Advair Diskus | 20 | $6,263 | $313 |
| Pradaxa | 11 | $3,449 | $314 |
| Oxycontin | 16 | $3,108 | $194 |
| Atorvastatin | 99 | $1,933 | $20 |
| Dextroamphetamine-Amphetamine | 24 | $1,320 | $55 |
| Metoprolol | 23 | $1,099 | $48 |
| Hydrocodone-Acetaminophen | 35 | $947 | $27 |
| Allopurinol | 29 | $748 | $26 |
| Levothyroxine | 34 | $737 | $22 |
| Tamsulosin | 27 | $671 | $25 |
| Omeprazole | 36 | $547 | $15 |
| Venlafaxine Hcl Er | 14 | $303 | $22 |
| Atenolol | 44 | $299 | $7 |
| Zolpidem | 21 | $239 | $11 |
| Losartan | 21 | $222 | $11 |
| Triamterene-Hydrochlorothiazid | 22 | $216 | $10 |
| Furosemide | 41 | $209 | $5 |
| Lisinopril | 22 | $157 | $7 |
| Prednisone | 12 | $131 | $11 |
| Simvastatin | 23 | $130 | $6 |
| Metformin | 12 | $111 | $9 |
| Metoprolol | 11 | $108 | $10 |
| Alprazolam | 15 | $106 | $7 |
| Lorazepam | 13 | $99 | $8 |
| Diazepam | 14 | $97 | $7 |
| Escitalopram | 14 | $90 | $6 |
| Azithromycin | 15 | $88 | $6 |
| Amlodipine Besylate | 17 | $85 | $5 |
| Lithium Carbonate | 11 | $27 | $2 |
2014: 29 drugs
| Zetia | 33 | $11,504 | $349 |
| Pradaxa | 12 | $3,515 | $293 |
| Atorvastatin | 69 | $2,452 | $36 |
| Valsartan-Hydrochlorothiazide | 12 | $1,026 | $85 |
| Hydrocodone-Acetaminophen | 30 | $884 | $29 |
| Omeprazole | 34 | $690 | $20 |
| Amphetamine Salt Combo | 11 | $686 | $62 |
| Losartan | 17 | $487 | $29 |
| Toprol Xl | 13 | $475 | $37 |
| Tamsulosin | 16 | $471 | $29 |
| Metoprolol | 12 | $470 | $39 |
| Levothyroxine | 23 | $427 | $19 |
| Triamterene-Hydrochlorothiazid | 21 | $292 | $14 |
| Allopurinol | 24 | $261 | $11 |
| Lisinopril | 28 | $239 | $9 |
| Atenolol | 35 | $233 | $7 |
| Simvastatin | 29 | $198 | $7 |
| Azithromycin | 16 | $135 | $8 |
| Latanoprost | 14 | $127 | $9 |
| Escitalopram | 13 | $118 | $9 |
| Furosemide | 30 | $115 | $4 |
| Metformin | 12 | $113 | $9 |
| Timolol Maleate | 12 | $104 | $9 |
| Alprazolam | 19 | $101 | $5 |
| Amlodipine Besylate | 11 | $95 | $9 |
| Lorazepam | 14 | $90 | $6 |
| Diazepam | 17 | $81 | $5 |
| Zolpidem | 13 | $55 | $4 |
| Citalopram Hbr | 12 | $46 | $4 |
2013: 25 drugs
| Zetia | 39 | $13,847 | $355 |
| Atorvastatin | 76 | $3,860 | $51 |
| Pradaxa | 12 | $3,094 | $258 |
| Advair Diskus | 11 | $2,720 | $247 |
| Amphetamine Salt Combo | 22 | $1,611 | $73 |
| Valsartan-Hydrochlorothiazide | 13 | $1,397 | $107 |
| Escitalopram | 16 | $1,200 | $75 |
| Hydrocodone-Acetaminophen | 49 | $910 | $19 |
| Omeprazole | 29 | $664 | $23 |
| Tamsulosin | 22 | $578 | $26 |
| Metoprolol | 11 | $505 | $46 |
| Levothyroxine | 30 | $444 | $15 |
| Latanoprost | 14 | $320 | $23 |
| Simvastatin | 21 | $240 | $11 |
| Lisinopril | 23 | $201 | $9 |
| Metoprolol | 22 | $164 | $7 |
| Alprazolam | 21 | $146 | $7 |
| Azithromycin | 15 | $137 | $9 |
| Atenolol | 17 | $128 | $8 |
| Allopurinol | 15 | $100 | $7 |
| Lorazepam | 11 | $96 | $9 |
| Metformin | 13 | $91 | $7 |
| Zolpidem | 13 | $91 | $7 |
| Furosemide | 13 | $49 | $4 |
| Prednisone | 11 | $40 | $4 |
Money from drug and device companies
Pulmonx Corporation
$1,734
Held by this doctor · 2019 · Shares of Common Stock That Have Not Been Registered Under the Securities Act of 1933
Published ownership or investment in a drug or device company. This is not proof that care is biased.
Professional record
- NPI
- 1720016942
- Licence
- CA G269110
- Trained
- Northwestern University Feinberg Medical School, 1970
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 747 Altos Oaks Dr, Los Altos, CA, 94024
- NPI first listed
- 2006-06-28
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.